Efficacy of nortriptyline and duloxetine for diabetic neuropathy
Not Applicable
- Conditions
- Diabet.Diabetes mellitusE10,E11,E1
- Registration Number
- IRCT201512265692N8
- Lead Sponsor
- Vice Chancellor for research- Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
patients over 18 years of age and At least three years have passed since the risk of diabetes and with pdn (painful diabetic neuropathy)For at least a month are. exclusion criteria: patients with epilepsy, htn uncontrolled and chronic liver disease or renal failure and patients treated for other causes pain in another part of their body.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method europathic pain. Timepoint: Before the intervention, the duration of the intervention for 35 days, at the end of intervention. Method of measurement: Visual Analogue Scale.
- Secondary Outcome Measures
Name Time Method Possible side effects of each drug. Timepoint: During the study period and at the end of the study. Method of measurement: According to Patients.